LCM
KRTX

Legato Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Legato Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,117
Closed -$354K – 632
2023
Q4 		$354K Sell
1,117
-1,232
-52% -$239K 0.05% 479
2023
Q3 		$397K Sell
2,349
-1,355
-37% -$255K 0.06% 443
2023
Q2 		$803K Hold
3,704
– – 0.11% 308
2023
Q1 		$673K Hold
3,704
– – 0.12% 282
2022
Q4 		$728K Buy
+3,704
New +$794K 0.14% 255

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Legato Capital Management's KRTX Position: Q1 2024 in Review

Legato Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,117 shares — an estimated $354K sold.

Legato Capital Management first reported a position in KRTX in Q4 2022 and held it in 5 quarters. The position peaked at $803K in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Legato Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Legato Capital Management sold 1,117 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $354K.
  • Legato Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Legato Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $803K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Legato Capital Management's 13F filing for Q1 2024, filed 15 Apr 2024.